免責聲明
本網站僅提供窩客幫資訊參考平台, 並不涉入其中任何諮詢、交易。本網站對各該窩客幫相關資訊亦不作任何實質或形式上之審查。本網站中所載一切窩客幫的資訊、文字、照片、圖形 、產權、廣告內容、或其他資料(以下簡稱『內容』)。無論其為公開張貼或私下傳送,若有不實或違法情事,均為『內容』提供者之責任,窩客幫概不負責也不承擔任何法律責任。
豐華生物科技股份有限公司
文章管理
Fi Asia Thailand 2025 Recap|Glac Highlights Postbiotics, Multi-Strain Probiotics, and CDMO Expertise
The three-day Fi Asia Thailand 2025 exhibition concluded successfully on September 17–19, 2025, at the Queen Sirikit National Convention Center in Bangkok.
Glac Biotech was honored to meet industry partners, clients, and experts from around the world, exchanging insights on the latest trends and applications in probiotics and postbiotics.

(Glac Biotech was invited by INGRAM to co-exhibit at this year’s event, further deepening our collaboration and increasing the regional visibility of our ingredients and technologies.)
 
 

Event Highlights

1. Comprehensive Capabilities Across Probiotics × Postbiotics × CDMO Development

At the exhibition, Glac Biotech presented its fully integrated development capabilities—from strain development, postbiotic manufacturing and raw material supply, to CDMO / ODM / OEM product support.
We are committed to providing end-to-end solutions, enabling brand partners to turn concepts into market-ready products with scientific validation and robust manufacturing processes.


2. Totipro® PE0401 (Postbiotics) as a Key Highlight

What is Totipro®?

Totipro® is Glac’s proprietary postbiotic ingredient line developed through an in-house fermentation and stabilization process.
It contains bioactive metabolites produced by specific probiotic strains, offering enhanced stability and formulation versatility.

Advantages of Postbiotics:

With high stability, heat tolerance, and no cold-chain requirements, Totipro® PE0401 is suitable for a wide range of product formats, including:

  • Cookies

  • Beverages

  • Chocolate

  • Capsules, tablets, and powder dietary supplements

Its cross-format compatibility makes postbiotics one of the fastest-growing ingredient categories in the global functional nutrition market.


3. International Recognition for PE0401

Totipro® PE0401 was awarded the 2023 NutraIngredients-Asia Awards – Ingredient of the Year: Microbiome Modulation,
one of the most respected distinctions in the international nutraceutical and microbiome industry.

PE0401 is among the few postbiotic ingredients in Asia to receive this honor, reflecting its leadership in scientific substantiation, formulation flexibility, and ingredient innovation.
 


 

🤝 Connecting With the Industry

Throughout the exhibition, Glac’s booth attracted continuous interest from visitors.
We engaged in in-depth discussions on technology, formulation design, and product development opportunities.

We extend our sincere appreciation to everyone who visited us and explored our raw materials and R&D capabilities.
Your support drives Glac Biotech’s commitment to advancing microbiome innovation.
We look forward to meeting you again at upcoming industry events.

 

 
相關文章
豐華生物科技股份有限公司
電話 : +886-6-589-1876 地址 : 1 F., No. 139, Sanmin St., Xinshi Dist., Tainan City 744007, Taiwan (R.O.C.) 信箱 : glac@glac.com.tw

  • 服務項目

  • 特別關鍵字